Chad Royer, longtime community advocate, who is a member of Bronx Board (CB7) and the chair of the CB7 veterans committee, ...

Key treatments for Alzheimer’s, rare cancers, and infectious diseases are under review, with new vaccines and therapies like ...

Single-cell RNA sequencing (scRNA-seq) has confirmed that MM exhibits high intra-tumor heterogeneity, comprising a mixture of ...

Annual whole-body, low-dose computed tomography (WBLDCT) can improve the management of smoldering multiple myeloma (SMM), ...

The UK's Medicines and Healthcare products Regulatory Agency (MHRA) has authorised GSK’s Blenrep for treating multiple ...

More information: Mun Yee Koh et al, The ADAR1-regulated cytoplasmic dsRNA-sensing pathway is a novel mechanism of lenalidomide resistance in multiple myeloma, Blood (2024). DOI: 10.1182/blood.

Marc Raab, MD, PhD, discussed the MajesTEC-5 trial of teclistamab plus standard myeloma therapies in transplant-eligible newly diagnosed multiple myeloma. The MajesTEC-5 trial (NCT05695508), a phase 2 ...

BMS prevails in antitrust lawsuit over its defense of multiple myeloma blockbuster Pomalyst By Kevin Dunleavy Apr 9, 2025 11:32am patent lawsuit Bristol Myers Squibb market exclusivity Celgene ...

Kumar holds leadership roles in multiple research initiatives, including serving as Chair of the Myeloma, Amyloidosis, and Dysproteinemia Group. Shaji’s research focuses on hematology and oncology, ...

Department of Nephrology, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an 710061, China ...

OGM provides a comprehensive genomic profile that can be used to support more precise prognostic risk stratification “Multiple myeloma is one of the most requested cancer types by customers ...